Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line
Shuqing Lü(Second Military Medical University), Jianmin Wang(Changhai Hospital), Jianmin Yang(Canadian Food Inspection Agency), Lieping Guo, Zhilong Chen(Donghua University), Hong Zhou, Li Chen(University of Kansas Medical Center), Shenglan Gong
Cited by 89
Related Papers
An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia
|Cancer Cell|2012|276
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
|The Lancet Haematology|2019|248
Fluidic Multivalent Membrane Nanointerface Enables Synergetic Enrichment of Circulating Tumor Cells with High Efficiency and Viability
|Journal of the American Chemical Society|2020|170
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease
|Journal of Clinical Investigation|2015|135